FRONTEO and Human Life Code to Use AI to Explore Mechanisms of Action of Cell Therapy Products | Yakugyo Nippo – Comprehensive Information Site for the Pharmaceutical Industry

The story

FRONTEO and Human Life Code announced that they have launched a project to analyze the mechanisms of action of cell therapy products.

The project uses AI to explore and analyze the mechanisms of action of cell therapies, suggesting that collaboration between the two companies could advance the use of AI drug discovery support services.

At a glance

Event summaryFRONTEO and Human Life Code have launched a project to analyze the mechanisms of action of cell therapy products.

Collaboration partnersFRONTEO and Human Life Code will collaborate on the project.

Target technologyThe companies plan to use AI to analyze and explore the mechanisms of action of cell therapy products.

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

nk.jiho.jpNews

PrimaryOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.